Pendopharm, a division of Pharmascience Inc., announced today that Health Canada has granted market authorization for Yorvipath(R) (palopegteriparatide injection), a parathyroid hormone (PTH) ...
Pendopharm, a division of Pharmascience Inc., announced today that Health Canada has granted market authorization for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results